Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection
Clinical trial NCT02613871 · COMPLETED
Trial details
- NCT number
- NCT02613871
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-22
- Primary completion
- 2017-01-04
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.